False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 6-7, 2010, Pages 461-468

  Boonsarngsuk, Viboon ^a   Niyompattama, Anuchit ^a   Teosirimongkol, Chalermporn ^a   Sriwanichrak, Kanchana ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERTAPENEM; GALACTOMANNAN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; VANCOMYCIN; ANTIINFECTIVE AGENT; FUNGUS ANTIGEN; MANNAN;

ADULT; ARTICLE; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; AGED; ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; ASPERGILLUS; BLOOD; CHEMISTRY; CHI SQUARE DISTRIBUTION; DISEASES; LABORATORY DIAGNOSIS; MIDDLE AGED; NONPARAMETRIC TEST; PREDICTIVE VALUE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; CHI-SQUARE DISTRIBUTION; DISEASE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MANNANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 77953241924     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365541003602064     Document Type: Article

References (34)

1. Ju MK, Joo DJ, Kim SJ, Chang HK, Kim MS, Kim SI, et al. Invasive pulmonary aspergillosis after solid organ transplantation: diagnosis and treatment based on 28 years of transplantation experience. Transplant Proc 2009;41: 375-378
2. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan- Amé S, Fohrer C, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008;47:1176-1184
3. Khayyata S, Soubani AO, Bonnett M, Nassar H, Abidi MH, Al-Abbadi MA. The major autopsy findings in adult patients after hematopoietic stem cell transplantation. Ann Transplant 2007;12:11-18
4. Gallien S, Fournier S, Porcher R, Bottero J, Ribaud P, Sulahian A, et al. Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases. Infection 2008;36:533-538
5. von Eiff M, Roos N, Schulten R, Hesse M, Zühlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995;62:341-347
6. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
7. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992;86:243-248
8. Reichenberger F, Habicht J, Matt P, Frei R, Solèr M, Bolliger CT, et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999;24:1195-1199
9. Stynen D, Goris A, Sarfati J, Latgé JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500.
10. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:1604-1610
11. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91: 311-318
12. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004;42: 5517-5522
13. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in hematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003;121: 448-457
14. Francis P, Lee JW, Hoffman A, Peter J, Francesconi A, Bacher J, et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection. J Infect Dis 1994;169:356-368
15. Verweij PE, Poulain D, Obayashi T, Patterson TF, Denning DW, Ponton J. Current trends in the detection of antigenaemia, metabolites, and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections. Med Mycol 1998;36(Suppl 1):S146-55.
16. Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 2008;27: 245-251
17. Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004;42: 4744-4748
18. Warke TJ, Kamath S, Fitch PS, Brown V, Shields MD, Ennis M. The repeatability of nonbronchoscopic bronchoalveolar lavage differential cell counts. Eur Respir J 2001;18:1009-1012
19. Perkins GD, Chatterjie S, McAuley DF, Gao F, Thickett DR. Role of nonbronchoscopic lavage for investigating alveolar inflammation and permeability in acute respiratory distress syndrome. Crit Care Med 2006;34:57-64.
20. Bart-Delabesse E, Basile M, Al Jijakli A, Souville D, Gay F, Philippe B, et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005;43: 5214-5220
21. Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007;44:1329-1336
22. Salonen J, Lehtonen OP, Teräsjärvi MR, Nikoskelainen J. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand J Infect Dis 2000;32:485-490
23. Siemann M, Koch-Dörfler M. The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis (IPA). Mycoses 2001;44:266-272
24. Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006;44:389-394
25. Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007;45:1759-1765 (Pubitemid 46933903)
26. Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, Wheat LJ, et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 2007;45:2787-2792 (Pubitemid 47417315)
27. Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997;40:353-357
28. Gould IM, Harvey G, Golder D, Reid TM, Watt SJ, Friend JA, et al. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens. Thorax 1994;49:999-1001.
29. Boselli E, Breilh D, Cannesson M, Xuereb F, Rimmelé T, Chassard D, et al. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Med 2004;30:976-979 (Pubitemid 38639495)
30. Levitt DG. PKQuest: capillary permeability limitation and plasma protein binding-application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics. BMC Clin Pharmacol 2002;2:7.
31. Boselli E, Breilh D, Duflo F, Saux MC, Debon R, Chassard D, et al. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia. Crit Care Med 2003;31:2102-2106
32. Wartenberg K, Tonak J, Knapp W. Lung tissue concentrations of cefoperazone. Infection 1983;11:280-282
33. Boselli E, Breilh D, Saux MC, Gordien JB, Allaouchiche B. Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia. Intensive Care Med 2006;32:2059-2062
34. Murashige N, Kami M, Kishi Y, Fujisaki G, Tanosaki R. False-positive results of Aspergillus enzyme-linked immunosorbent assays for a patient with gastrointestinal graft-versushost disease taking a nutrient containing soybean protein. Clin Infect Dis 2005;40:333-334